Li QK - Search Results

1

De novo lipogenesis represents a therapeutic target in mutant Kras non-small cell lung cancer.

Singh A, Ruiz C, Bhalla K, Haley JA, Li QK, Acquaah-Mensah G, Montal E, Sudini KR, Skoulidis F, Wistuba II, Papadimitrakopoulou V, Heymach JV, Boros LG, Gabrielson E, Carretero J, Wong KK, Haley JD, Biswal S, Girnun GD. Singh A, et al. Among authors: li qk. FASEB J. 2018 Jun 15;32(12):fj201800204. doi: 10.1096/fj.201800204. Online ahead of print. FASEB J. 2018. PMID: 29906244 Free PMC article.

2

The utility of napsin-A in the identification of primary and metastatic lung adenocarcinoma among cytologically poorly differentiated carcinomas.

Stoll LM, Johnson MW, Gabrielson E, Askin F, Clark DP, Li QK. Stoll LM, et al. Among authors: li qk. Cancer Cytopathol. 2010 Dec 25;118(6):441-9. doi: 10.1002/cncy.20108. Epub 2010 Sep 9. Cancer Cytopathol. 2010. PMID: 20830690 Free article.

3

KEAP1 gene mutations and NRF2 activation are common in pulmonary papillary adenocarcinoma.

Li QK, Singh A, Biswal S, Askin F, Gabrielson E. Li QK, et al. J Hum Genet. 2011 Mar;56(3):230-4. doi: 10.1038/jhg.2010.172. Epub 2011 Jan 20. J Hum Genet. 2011. PMID: 21248763 Free PMC article.

4

EGFR and KRAS mutations in metastatic lung adenocarcinomas.

Munfus-McCray D, Harada S, Adams C, Askin F, Clark D, Gabrielson E, Li QK. Munfus-McCray D, et al. Among authors: li qk. Hum Pathol. 2011 Oct;42(10):1447-53. doi: 10.1016/j.humpath.2010.12.011. Epub 2011 Apr 15. Hum Pathol. 2011. PMID: 21497370

5

Improvement of cellularity on cell block preparations using the so-called tissue coagulum clot method during endobronchial ultrasound-guided transbronchial fine-needle aspiration.

Yung RC, Otell S, Illei P, Clark DP, Feller-Kopman D, Yarmus L, Askin F, Gabrielson E, Li QK. Yung RC, et al. Among authors: li qk. Cancer Cytopathol. 2012 Jun 25;120(3):185-95. doi: 10.1002/cncy.20199. Epub 2011 Dec 5. Cancer Cytopathol. 2012. PMID: 22144401 Free PMC article.

6

Application of glycoproteomics for the discovery of biomarkers in lung cancer.

Li QK, Gabrielson E, Zhang H. Li QK, et al. Proteomics Clin Appl. 2012 Jun;6(5-6):244-56. doi: 10.1002/prca.201100042. Proteomics Clin Appl. 2012. PMID: 22641610 Free PMC article. Review.

7

Comparison of EGFR and KRAS mutations in primary and unpaired metastatic lung adenocarcinoma with potential chemotherapy effect.

Munfus-McCray D, Cui M, Zhang Z, Gabrielson E, Askin F, Li QK. Munfus-McCray D, et al. Among authors: li qk. Hum Pathol. 2013 Jul;44(7):1286-92. doi: 10.1016/j.humpath.2012.10.016. Epub 2013 Jan 18. Hum Pathol. 2013. PMID: 23337026

8

Glycoproteomic analysis of bronchoalveolar lavage (BAL) fluid identifies tumor-associated glycoproteins from lung adenocarcinoma.

Li QK, Shah P, Li Y, Aiyetan PO, Chen J, Yung R, Molena D, Gabrielson E, Askin F, Chan DW, Zhang H. Li QK, et al. Among authors: li y. J Proteome Res. 2013 Aug 2;12(8):3689-96. doi: 10.1021/pr400274w. Epub 2013 Jul 11. J Proteome Res. 2013. PMID: 23802180 Free PMC article.

9

Aberrant Mucin5B expression in lung adenocarcinomas detected by iTRAQ labeling quantitative proteomics and immunohistochemistry.

Li Y, Wang X, Ao M, Gabrielson E, Askin F, Zhang H, Li QK. Li Y, et al. Among authors: li qk. Clin Proteomics. 2013 Nov 1;10(1):15. doi: 10.1186/1559-0275-10-15. Clin Proteomics. 2013. PMID: 24176033 Free PMC article.

10

The utility of a novel triple marker (combination of TTF1, napsin A, and p40) in the subclassification of non-small cell lung cancer.

Ao MH, Zhang H, Sakowski L, Sharma R, Illei PB, Gabrielson E, Askin F, Li QK. Ao MH, et al. Among authors: li qk. Hum Pathol. 2014 May;45(5):926-34. doi: 10.1016/j.humpath.2014.01.005. Epub 2014 Jan 25. Hum Pathol. 2014. PMID: 24746197 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

157 results

Search Page